Therapeutic management of allergic rhinitis: a survey of otolaryngology and allergology specialists
European Archives of Oto-Rhino-Laryngology · 2023-07 · 280 (7) · 3469-3474
DOI: 10.1007/s00405-023-07955-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 05.04.2023. Verfasst von Carlos Colás und 3 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Alergología, Hospital Clínico-Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, Zaragoza, Spain. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Otolaryngology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Mylan Pharmaceuticals, SL.
Abstract (Originalsprache)
PURPOSE: To describe the current management of allergic rhinitis (AR) in Spain's specialized care according to the next-generation ARIA guidelines. METHODS: An ad hoc online survey was distributed to AR specialists to appraise their perceptions of pathology management, knowledge of next-generation ARIA guidelines (including four case clinics), and their views on the principal barriers and the actions to proper AR management. RESULTS: one hundred nine specialists (38.5% allergists and 61.5% otolaryngologists) completed the study survey. Most respondents (87.2%) had read all or part of the Next-Generation ARIA Guidelines, and 81.6% stated that they considered the patient's treatment choice preferences. However, only 20.2% of specialists answered according to the recommendations in at least three of the four case clinics. Most participants failed to fulfill the treatment duration according to the guidelines. They regarded the lack of multidisciplinary teams (21.7%) and the lack of patients' AR treatment adherence (30.6%) as the most critical healthcare system- and patient-related barriers to the correct management of AR, respectively. Promoting patients' education was considered the most crucial action to improve it. CONCLUSION: Despite specialists' awareness, there is a gap between the evidence-based guidelines' recommendations and their implementation in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servicio de Alergología, Hospital Clínico-Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, Zaragoza, Spain.
- Viatris Pharmaceuticals, S.L., Madrid, Spain.
- Outcomes'10, S.L.U, Castellón de la Plana, Spain.
- Unidad de Rinología y Base de Cráneo, Servicio de Otorrinolaringología, Hospital Clínico, Universidad de Barcelona, Barcelona, Spain. ialobid@clinic.cat.
Förderung
- Mylan Pharmaceuticals, SL
Zitieren
APA
Colás, C., Álvarez-Suárez, M. E., Benedito-Palos, L., & Alobid, I. (2023). Therapeutic management of allergic rhinitis: a survey of otolaryngology and allergology specialists. European Archives of Oto-Rhino-Laryngology, 280(7), 3469-3474. https://doi.org/10.1007/s00405-023-07955-5
Vancouver
Colás C, Álvarez-Suárez ME, Benedito-Palos L, Alobid I. Therapeutic management of allergic rhinitis: a survey of otolaryngology and allergology specialists. European Archives of Oto-Rhino-Laryngology. 2023;280(7):3469-3474. doi:10.1007/s00405-023-07955-5
BibTeX
@article{Cols2023,
author = {Colás, Carlos and Álvarez-Suárez, María Elena and Benedito-Palos, Laura and Alobid, Isam},
title = {Therapeutic management of allergic rhinitis: a survey of otolaryngology and allergology specialists},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2023},
volume = {280},
number = {7},
pages = {3469--3474},
doi = {10.1007/s00405-023-07955-5}
}
EUVIMED